Artemisinic Acid Market Overview
The Artemisinic Acid Market is witnessing strong growth driven by rising demand for artemisinin derivatives, particularly for malaria treatments. Advancements in bioengineering, synthetic biology, extraction technologies, and sustainable production methods are improving manufacturing efficiency while strengthening supply chain reliability. Growing research into new artemisinin derivatives is also creating opportunities for broader therapeutic applications.
According to the WiseGuyReports report, the global Artemisinic Acid Market was valued at USD 1.5 billion in 2024 and USD 1.6 billion in 2025, and is projected to reach USD 3.5 billion by 2035, expanding at a CAGR of 8.1% during 2025–2035. Asia Pacific is anticipated to lead the market, supported by strong production capabilities, rising healthcare expenditure, and demand for antimalarial drugs, with the regional market projected to reach USD 1.167 billion by 2035. The Pharmaceuticals application segment was valued at USD 640 million in 2024 and is projected to reach USD 1.28 billion by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/artemisinic-acid-market
Key players in the Artemisinic Acid Market include:
Novartis
Shenzhen E Jia Pharmaceutical
Guilin Pharmaceutical
Hunan Changde Pharmaceutical
BASF
Hikma Pharmaceuticals
Marlabs
Daiichi Sankyo
F. HoffmannLa Roche
Sanofi
Boehringer Ingelheim
Eumedica
Market dynamics are being shaped by rising demand for antimalarial drugs, increasing malaria prevalence, advancements in extraction technologies, regulatory support for artemisinin derivatives, and growing investment in sustainable agriculture. The shift toward bioengineering and synthetic production is also supporting scalable and cost-efficient manufacturing.
The market is segmented by Application into Pharmaceuticals, Agriculture, Cosmetics, and Nutraceuticals; by Source into Natural Extraction and Synthetic Production; by End Use Industry into Healthcare, Agricultural Chemicals, Food and Beverage, and Personal Care; by Formulation Type into Active Ingredients and Intermediate Compounds; and by Region into North America, Europe, South America, Asia Pacific, and Middle East and Africa.
Growth opportunities are emerging from increased demand for antimalarial drugs, expanding pharmaceutical applications, research into cancer treatment, advancements in synthetic production methods, and rising awareness of natural remedies. Companies can also benefit by investing in biotechnology partnerships, sustainable production processes, regional manufacturing capacity, and emerging malaria-endemic markets.
Recent Developments and Market Trends:
Guilin Pharmaceutical announced a strategic partnership with Sanofi in May 2024 to secure long-term artesunate API supply and co-develop new artemisinic acid derivatives.
BASF announced a collaboration with Hunan Changde Pharmaceutical in November 2024 to scale up fermentation-based artemisinic acid production.
Daiichi Sankyo announced in March 2025 the acquisition of a minority stake in Shenzhen E Jia Pharmaceutical’s artemisinin intermediate unit to strengthen supply security.
Advancements in bioengineering and synthetic biology are enabling more efficient and sustainable artemisinic acid production.
Growing demand for artemisinin derivatives and sustainable agricultural practices is supporting market expansion.
Reasons to Buy the Report:
Gain detailed insights into the global Artemisinic Acid Market size, growth outlook, and competitive landscape.
Understand the major market drivers, trends, opportunities, and technological developments shaping the industry.
Assess market performance across application, source, end-use industry, formulation type, and regional segments.
Identify leading companies and evaluate their strategic positioning within the competitive landscape.
Understand emerging opportunities created by antimalarial drug demand, sustainable production, and expanding pharmaceutical applications.
Future Outlook:
The Artemisinic Acid Market is expected to maintain steady growth through 2035, supported by increasing demand for antimalarial drugs, advances in biotechnology, sustainable production initiatives, and expanding pharmaceutical applications. Pharmaceuticals is expected to remain the dominant application, reaching USD 1.28 billion by 2035, while Asia Pacific is projected to remain the leading regional market at approximately USD 1.167 billion. Natural Extraction currently holds a majority position within the source segment, while Synthetic Production is gaining traction because of its scalability and consistency. Overall, the global Artemisinic Acid Market is forecast to reach USD 3.5 billion by 2035 at a CAGR of 8.1% during 2025–2035.
➤➤Explore Our Latest Related Reports:
